![]() All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Top 10 Mutual Funds Holding UNITY Biotechnology Inc Mutual fund Top 10 Owners of UNITY Biotechnology Inc Stockholder Bought 312.0 Thousand shares of UNITY Biotechnology IncĭIMENSIONAL FUND ADVISORS LP Bought 37.5 Thousand shares of UNITY Biotechnology IncīLACKROCK FUND ADVISORS Bought 36.3 Thousand shares of UNITY Biotechnology Inc “Moving forward we will have a leaner and more agile team, which is well-resourced to advance our pipeline programs to key milestones,” Ghosh added later.Transactions Latest Institutional Activity įIDELITY MANAGEMENT & RESEARCH C. Events and Presentations Unity Biotechnology Investors & Media Events & Presentations Latest Presentation Corporate Presentation April 2023 UBX1325 Phase 2 BEHOLD 24-week Data Investor Call Presentation Upcoming Events There are no upcoming events available at this time. The company says the staff reduction will extend its cash runway through mid-2022, and it’s going to keep pushing its pipeline toward the clinic. Unity Biotechnology employs 65 staff and has a trailing 12-month revenue of. “Unity is a pioneer in the development of therapeutics targeting senescent cells at the crux of many age-related diseases, and we will continue to build on this scientific foundation as we advance our pipeline,” Ghosh said in a statement. Best Biotech Stocks Under 2 Biotricity Inc. If all goes according to plan, Unity expects to dose the first patients in a Phase I study of UBX1325 later this year. Plus, the biotech is keeping UBX1967 in its pocket - a “molecularly distinct backup to UBX1325.” (UNITY) Nasdaq: UBX, a biotechnology company developing therapeutics to slow, halt, or reverse. It’s designed to target Bcl-xL, thus eliminating senescent cells to potentially treat age-related eye diseases. 12, 2022 (GLOBE NEWSWIRE) - UNITY Biotechnology, Inc. The biotech is hoping to send its diabetic macular edema candidate, UBX1325, into Phase I by the end of the year. “Not only because of work we’ve done internally, but also because of the wealth of data from labs that continue to indicate both that senescent cells accumulate during diseases of aging and that eliminating them with targeted mechanisms can provide benefit.” Patients on the treatment arms showed virtually no difference compared to patients on the placebo arm, and as a result of the news, the biotech’s market value plunged 60%.ĭespite the setback, CEO Anirvan Ghosh remained confident in Unity’s preclinical pipeline. “Our confidence in senescent cells driving disease biology remains strong,” he told investors last month. But last month, it missed the mark in a 183-person Phase II study testing UBX0101 for osteoarthritis of the knee. In the last 10 years, Unity has attracted investors like Jeff Bezos, Peter Thiel and Arch Venture Partners’ Bob Nelsen - raking in more than $200 million in funding. It’s yet another blow to the celebrity-funded biotech, which has been laser-focused on clearing senescent cells to potentially reduce the symptoms of aging. The staff reduction will leave San Francisco-based Unity $UBX with 75 full-time employees by the end of the year. And now, 30% of its staff are next, as the company restructures to focus on ophthalmology and neurology. Unity Biotechnology’s lead anti-aging program faced the chopping block last month following a major Phase II flop.
0 Comments
Leave a Reply. |